KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Invested Capital (2016 - 2025)

Historic Invested Capital for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $18.7 billion.

  • Vertex Pharmaceuticals' Invested Capital rose 1293.71% to $18.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.7 billion, marking a year-over-year increase of 1293.71%. This contributed to the annual value of $18.7 billion for FY2025, which is 1293.71% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Invested Capital stood at $18.7 billion for Q4 2025, which was up 1293.71% from $17.3 billion recorded in Q3 2025.
  • Vertex Pharmaceuticals' Invested Capital's 5-year high stood at $18.7 billion during Q4 2025, with a 5-year trough of $9.0 billion in Q1 2021.
  • In the last 5 years, Vertex Pharmaceuticals' Invested Capital had a median value of $15.1 billion in 2023 and averaged $14.4 billion.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Invested Capital skyrocketed by 3897.83% in 2021 and then plummeted by 1105.49% in 2025.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Invested Capital stood at $10.7 billion in 2021, then surged by 34.98% to $14.4 billion in 2022, then grew by 25.19% to $18.0 billion in 2023, then fell by 8.22% to $16.5 billion in 2024, then grew by 12.94% to $18.7 billion in 2025.
  • Its last three reported values are $18.7 billion in Q4 2025, $17.3 billion for Q3 2025, and $17.2 billion during Q2 2025.